Type 1 fimbriate strains of escherichia coli initiate renal parenchymal scarring  by Topley, N. et al.
Kidney International, Vol. 36 (1989), pp. 609—616
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Type 1 fimbriate strains of escherichia coli initiate renal parenchymal
scarring. The renal scarring which characterizes chronic pyelonephritis
is initiated by bacterial infection and is independent on the activation of
an inflammatory response. Although the presence of polymorphonu-
clear leukocytes (PMN) is essential for initiating the scarring process,
the bacterial structures responsible for their activation have not been
investigated. In an animal model of chronic pyelonephritis the surface
area of the renal scars produced by Type 1 fimbriate escherichia coli (E.
coli) was significantly greater than that of those produced by P fimbriate
and non-fimbriate strains (P < 0.01). The activation of human PMN by
the same Type 1 fimbriate organisms resulted in a significant release of
lysosomal neutral protease activity (P < 0.001) and activation of the
respiratory burst (P < 0.01). The neutral protease release in response to
P fimbriate and non-fimbriate organisms was not significantly increased.
The extent of renal scarring also correlated with the release of neutral
protease activity (P < 0.02) and with the degree of activation of the
respiratory burst (P < 0.05). These results demonstrate that the ability
of E. coli strains to cause renal scars may be related to their capacity to
express Type I fimbria, which may be a causative factor in the in vivo
activation of the inflammatory response.
Renal scarring is the major histopathological feature of
chronic pyelonephritis. In the human kidney scarring is initiated
in infancy following episodes of acute pyelonephritis [1] and is
usually associated with the presence of severe grade vesico-
ureteric reflux [2—4]. Recent studies using animal models have
demonstrated a poor correlation between the extent of patho-
logical damage and intrarenal bacterial growth during acute
infection, although the bacterial load at the initiation of the
inflammatory response may be important [5—8]. While the
precise mechanism by which scarring is initiated is poorly
understood, an inflammatory response within the kidney is
essential, and tissue damage and eventual scar formation are
dependent on the presence of leukocytes in the renal paren-
chyma [9, 10]. It has been demonstrated that the infiltration of
leukocytes into infected kidneys is associated with the destruc-
tion of tubular basement membrane and tubular epithelium, and
that the greatest degree of tissue damage occurs at the site of
maximum leukocyte infiltration [7, 9, 10]. These observations
suggest that the event which triggers the scarring process is the
initial interaction of invading pathogens and host inflammatory
cells.
Escherichia coli (E. co/i) strains causing acute pyelonephritis
have been characterized in vitro in terms of their high frequency
of expression of certain genotypic characteristics or virulence
markers. These include a restricted range of 0 serotypes [11], a
high frequency of mannose resistant hemagglutinins (MRHA
and/or P-fimbriation) [12, 13], a restricted number of K antigens
[14], resistance to complement mediated lysis [15] and the
capacity to produce a-hemolysin [16]. Expression of such
virulence factors, however, occurs much less frequently in E.
coil strains isolated from individuals with VUR [17], the pa-
tients in whom scarring most frequently occurs.
It is well established that Type 1 fimbriate strains of E. coil
bind to PMN more readily than non-fimbriate or P-fimbriate
strains [18, 19]. In addition, we have recently shown that those
strains of E. co/i expressing Type 1 fimbria are capable of
causing significant release of lysosomal neutral protease (in-
cluding elastase) from human neutrophils (PMN) [20]. Type 1
fimbriate E. coil are also capable of initiating the respiratory
burst of human PMN [19, 21], thus causing the generation of
toxic oxygen species, which may be microbicidal [22, 231. To
assess the possible role of these surface fimbrial characteristics
in the initiation of the scarring process, the present study
examined the ability of a number of defined strains of E. coil to
cause renal scarring in an animal model of pyelonephritis. The
severity of the subsequent scarring was quantified both mor-
phologically and histologically, and was compared to the in
vitro ability of these strains to cause lysosomal neutral protease
release and generation of toxic oxygen metabolites from PMN.
There was a significant overall relationship between the in vitro
capacity of Type 1 fimbriate organisms to activate PMN and
their in vivo capacity to cause scarring.
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Reagents
All chemicals and reagents used in this work were Analar
grade and obtained from British Drug Houses (BDH) Ltd.
(Poole, UK) unless otherwise stated.
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Table 1. Genotypic characteristics of F. coil strains
E. coil straina 0 serotype
Hemolysin Fimbriation
(genotypic)
Type I P
SC
504
168
AB
NK1
KS7I
417
49
7
GG2
88
12
ER2
01
06
04
NT
04
06
01
08
018
04
NT
04
04
— —
+ +
+ +
- -
+ +
+ +
+ ÷
— +
— —
+ +
- —
+ +
+ +
+
+
—
-
+
+
+
—
+
+
+
—
+
NT: not 01, 02, 03, 04, 05, 06, 07, 08, 09, 011, 015, 017, 018, 025 or
075.
a All strains used in this study were isolated from symptomatic
urinary tract infections except strain AB which was an isolate from an
asymptomatic infection.
Bacterial strains
Thirteen uropathogenic strains of E. co/i (504, SC, 12, K571,
NK, 417, 49, 168, AB, ER2, GG2, 7 and 88; Table 1) were
subcultured in at least one of the following growth media:
nutrient broth No. 2; Diagnostic Sensitivity Testing (DST) agar
(Oxoid Ltd., Basingstoke, UK); pooled, filter sterilized, human
urine; or Modified Vogel-Bonners Medium (MVBM) [24]. The
bacterial cells were harvested by centrifugation, washed, resus-
pended in phosphate buffered saline (PBS) pH 7.3 to an optical
density at 560 nm of 1.0 (= 5 x I0 cfu/ml).
Bacterial fimbriation
Bacterial fimbriation was assessed by mannose sensitive
hemagglutination of guinea pig and human erythrocytes, and P
fimbrial expression was confirmed using the PF test (Orion
Diagnostica, Espoo, Finland). To assess genotypic capacity for
fimbrial expression, bacterial strains were repeatedly subcul-
tured up to 20 times in the growth media described until a stable
pattern of fimbriation was maintained over a number of subcul-
tures.
Bacterial stimulation of renal scarring
All experiments were performed in female Wistar rats aged
three months and weighing 150 to 200 g. The animals were kept
at room temperature and fed Pilsbury rat diet (Pilsbury Ltd.,
Birmingham, UK) and water ad libitum.
All surgical procedures were performed under ether anaes-
thesia. The left kidney of each rat (innoculated in 25 groups of
6) was exposed, and 2.5 x iO cfu in a total volume of 50 tl
were innoculated at a depth of 2 mm with a 26 gauge needle into
the middle part of the outer convex border of the kidney.
Control animals received similar injections of PBS or sterile
growth medium. The animals were sacrificed at six weeks and
both kidneys were removed and examined.
Planimetric measurement of scarred kidneys
Decapsulated whole rat kidneys were fixed in 10% vol/vol
formal saline, pH 7.3, for at least 48 hours prior to photographic
and histological procedures. All the specimens were grouped
and mounted on black card and photographed under the same
lighting conditions and at the same magnification.
Prints were magnified (x 7) and the external area of scar
analyzed using a Kontron-MOP videoplan-image analysis pro-
gram (Reichert-Jung Ltd., Cambridge, UK). Briefly, the perim-
eter of the scar was traced using the activated cursor and an
accurate measure of the surface area of the scar was obtained.
Each scar was measured by three independent laboratory
personnel and a mean external scarring area (±sD) was ob-
tained for each group of kidneys. Repeated measurement by
one observer of the same kidney scar showed a coefficient
variation of 3.9%. There was an inter-observer coefficient of
variation of 15.1%.
Histological examination of scarred kidneys
Decapsulated, fixed, whole kidneys were dehydrated in an
ethanol gradient (50 to 100% ethanol) for 14 hours, cleared with
histosol (Shandon Southern Products Ltd., Runcorn, UK) for
six hours and impregnated with paraffin wax in a Histokinette
(Hughes and Hughes Ltd., Romford, UK). The impregnated
tissue was then embedded in paraffin wax, rapidly cooled and
stored at 4°C until cut. Serial sections (3 pm) were cut on an
"820" Spencer Rotary Microtome (American Optical Corpora-
tion, Buffalo, New York, USA) through the scarred area of
each kidney and mounted on glass slides prior to staining in
hematoxylin and eosin. The fixed and stained preparations were
then mounted in De Pex (BDH Ltd.) and examined.
Histological lesions were scored by three independent labo-
ratory personnel on an arbitrary scale of 1 to 10 based on the
severity and diffuseness of the cellular infiltrate in the renal
cortex. The coefficients of variation for the combined histolog-
ical scores obtained in this way ranged from 14.1% to 31.1%.
Production of a-hemolysin by E. coIl strains
E. co/i strains were grown overnight in 20 ml of modified
nutrient broth No. 2 (MNB; Oxoid nutrient broth No. 2
containing 2 g/l D-glucose). A 500 d innoculum of this culture
was then added to a further 20 ml of MNB and incubated at 37°C
for four to five hours to ensure logarithmic growth. The bacteria
were harvested by centrifugation, washed and resuspended in
20 ml Davies and mingioli minimal medium (DMMM) [25]. To
this culture 100 d of 20 mg/ml bovine hemoglobin (Sigma
Chemical Co., Poole, UK) was added to enhance hemolysin
production and the mixture was incubated at 30°C with shaking.
a-Hemolysin is produced maximally during logarithmic growth,
and in order to estimate maximal expression a I ml sample of
culture was removed at hourly intervals and spun down for one
minute in an MSE microfuge (MSE Ltd., Crawley, UK) at
11,000 x g. Five hundred microliters of the supernatant ob-
tained as described above was then mixed with 100 d of 0.1 M
Tris-HCI, 100 j.d 0.2 M CaCI2, 100 d 0.15 M NaCI and 100 Ml of
10% vol/vol human erythrocytes (HRBC; obtained from defi-
brinated blood on the day of the experiment). This mixture was
incubated at 40°C for 10 minutes and then centrifuged at 700 x
g for two minutes to remove non-lysed HRBC. One hundred
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microliters of the supernatant was then diluted with 2.9 ml of
distilled water and the optical density of the sample was
measured at 420 nm against the appropriate blank. The maxi-
mum potential expression of a-hemolysin by each strain was
then calculated as a percentage of that occurring following total
HRBC lysis in distilled water.
Human PMN preparation
Normal human leukocytes were isolated from citrated periph-
eral blood by dextran sedimentation and rendered plasma-free
and platelet-poor by washing three times with PBS. PMN were
purified by density gradient centrifugation at 400 x g for 35
minutes at 23°C on cushions of Ficoll-Hypaque (Pharmacia
Ltd., Milton Keynes, UK). Following hypotonic lysis of eryth-
rocytes and washing, the PMN were counted in a Coulter
counter ZM (Coulter Electronics Ltd., Luton, UK) and resus-
pended to a concentration of 5 x 106 cells/mI PBS. Microscopic
examination of Wright's stained Cytospin II (Shandon Southern
Products Ltd.) preparations revealed that the cells were >98%
PMN.
Chemiluminescence (CL) assay
One hundred microliters of suspended PMN (5 x l0 cells)
were incubated with 100 p1 of 10 M 5-amino 2,3-dihydro
l,4-phthalazine dione (luminol) (Sigma) and 200 p1 Krebs
Ringer phosphate buffer containing 0.54 mr'i Ca2 and 11.0mM
D-glucose pH 7.4 (KRPG) at 37°C for six minutes prior to
addition of 100 pi of each bacterial suspension (l0 efu/mi), in
order to equilibrate temperature and record background CL. At
precise two minute intervals following addition of E. co/i, CL
readings were taken in a Lumac Biocounter 2010 (Lumac
MvbV, Landgraaf, Netherlands) and peak levels were com-
pared to those of unstimulated PMN incubations [21, 26].
Enzyme release assays
Two hundred microliters of a PMN suspension (I x 106 cells)
were incubated with 200 p1 of bacterial suspension and 600 p1 of
KRPG at 37°C for times up to one hour. At the end of the
incubation period the cells and bacteria were pelleted by
centrifugation for one minute at 11,000 x g, and duplicate
samples were assayed for neutral protease and lactate dehydro-
genase (LDH) activity [20].
In each experiment, control incubations were included con-
sisting of PMN incubated in KRPG only, bacteria incubated in
KRPG only and PMN incubated with the calcium ionophore
A23 187 (Calbiochem, Cambridge, Massachusetts, USA) at 5
M concentration. The percentage release of enzymes from the
PMN was calculated, after subtraction of the appropriate blank
values, as a percentage of that released from cells disrupted by
sonication at 4°C, for two periods of one minute at 8 sm peak to
peak distance, in an MSE 150 W ultrasonic disintegrator (MSE
Ltd., Crawley, UK) [20].
Neutral protease
Fifty microliters of PMN supernatant was added to 50 p1 (0.1
mg) of [3H]-casein (0.41 tCi/mg) [20] in phosphate buffer (pH
7.0) containing 1 mrvi CaCI2 and incubated for 16 hours at 37°C.
Two hundred and fifty microliters of ice-cold 11% wt/vol
tricholoracetic acid (TCA) was added. Following incubation for
30 minutes at 4°C the non-hydrolysed casein was precipitated
Table 2.
Phenotypic
fimbrial
expression Meanscar area
E. co/i strain Growth medium" Type 1 p mm2 SD
504 NB
UR
MVBM
—
— —
— —
8864±3494
4640±5622
4281 2156
AB NB
UR
MVBM
— —
— —
— —
598±533
3222 2312
2795 818
168 NB
UR
MVBM
—
— —
— —
6774 3372
4884 2983
3820 2982
SC
NK1
NB
UR
MVBM
Agar
NB
— +
— +
— —
— ++
++ +
3533 2987
1858 1216
3255 2801
1803 934
3891±3290
Agar — ++ 7738 3894
KS7I NB
Agar
+++ +
— ++
5337 5845
5186 4028
49 NB +++ — 5560±4465
7 NB — + 1929±1876
GG NB ++ ++ 9312±4678
88 NB — ÷ 3038 2751
12 NB ++ — 7869 3392
ER2 Agar — ++ 1016 1047
417 NB
Agar
+++ ÷
— +
2614 1436
2099 2414
by centrifugation at 11,000 x g for five minutes. One hundred
and seventy-five microliters of supernatant containing the hy-
drolysed product was then assayed for released radioactivity.
Lactate dehydrogenase
Three hundred microliters of PMN supernatant and 200 1.d of
10 m reduced f3-nicotinamide adenine dinucleotide (NADH;
Sigma) was added to 2.4 ml of 0.1 M phosphate buffer, pH 7.4.
The reaction was started with 100 p1 of potassium pyruvate (1
mg/mI) and the rate of change in absorbance at 340 nm was
measured over four minutes at room temperature on a Cecil CE
292 spectrophotometer (Cecil Instruments Ltd., Cambridge,
UK).
Statistical analysis
Significant differences between populations were tested using
the Mann Whitney U-test. Correlations between groups of data
were tested using the Spearman rank correlation coefficient.
Results
Area of external scarring of rat kidneys
Strains of E. co/i with the genotypic capacity for Type I
fimbrial expression were associated with significantly greater
areas of scarring than P-fimbriate strains when injected into rat
kidneys irrespective of the medium in which they were grown(Z =
—2.70; P < 0.01; Fig. IA). In addition phenotypic
expression of Type 1 fimbria byE. co/i strains at the time of the
injection (Table 2) was also associated with scars of signifi-
"NB: only those
nutrient broth No.
experiments.
strains which had been grown on DST agar or in
2 were used in the lysosomal enzyme release
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Fig. 1. Area of external scar of rat kidneys 6 weeks after the injection of one of each of 13 strains of E. coli grown in d(fferent media (Table 2).
Each point represents themean areaof the scars from the kidneys of 6 different animals each injected with 2,5 x iO cfu of one of the 25 bacterial
culture. A. Subdivided according to fimbrial genotype, irrespective of culture medium used and of the phenotypic expression of fimbria at the time
of injection (• = nutrientbroth; A = agar; pooled sterile urine; V = MVI3M). B. Subdivided according to the actual (phenotypic) expression
of fimbriae at the time of injection.
Fig. 2. Rat kidneys 6 weeks after the injection of' A. E. co/i strain
504 (Type I and P-fimbriate); B. E. co/i strain AB (non-fimbriate); C.
E. co/i strain SC (P-fimbria).
cantly greater area than those seen following the injection of P-fimbriate group (the largest being formed following the injec-
non-fimbriate (Z = —2.70; P < 0.01) or P-fimbriate strains (Z = tion of strains with the genotypic capacity for Type 1 fimbrial
—2.47; P < 0.02; Figs. lB and 2). This difference reached synthesis).
significance despite a large variation in the scar size of the Inflammatory cell infiltration was observed histologically in
Neutral protease release from human PMN
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Strains of E. coli grown on agar or in static broth and
expressing Type I fimbria, whether alone or with P-fimbria,
caused significant neutral protease release (Z =
—3.24; P =
0.001) from human PMN in vitro (Fig. 5) without causing
significant release (<5%) of the cytoplasmic marker LDH. In
contrast those strains expressing P fimbria alone, or non-
fimbriate strains, did not cause significant neutral protease
release. There was a significant correlation between the area of
scarring following injection of an individual strain and the
ability of that strain to release neutral protease activity from
human PMN (Z = 2.39; P < 0.02; Fig. 6). In addition, the mean
percentage neutral protease activity, released after 60 minutes,
from human PMN stimulated by Type I fimbriate organisms
(25.83 16.9%, N = 9) was similar to that released following
incubation for 60 minutes with 5 M A23 187 (30.6 6.1%, N =
10).
Hemolytic potential and scarring
There was no significant correlation between the hemolytic
capacity of a strain and the area of scarring produced following
the injection of that strain (Z = 1.10; Fig. 7).
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Fig. 4. Area of external scars of rat kidneys 6 weeks after injection with
one of /3 strains of E. coil grown in different media (Table 2) compared
with the PMN CL response (expressed as Log.cps.) to the same strain
__________
bearing the same surface phenotype following growth in the samei e 1 + medium. Each point represents the mean scar area of 6 kidneys injectedVP with the same organism compared with the mean of duplicate PMN CL
determinations with PMN from 3 different donors.
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Fig. 3. Peak PMN CL (expressed as Log.cps.) in response to stimula-
tion with each of the 13 strains of E. coli grown in different ,nedia
(Table 2). Each point represents the mean of duplicate CL determina-
tions obtained in 3 separate experiments with PMN from different
donors and strains expressing the same phenotypic fimbriation pattern
as in Fig. lB.
all the infected kidneys sectioned, even in those kidneys with an
external scar no larger than the saline control group. There was,
however, no statistically significant relationship of inflamma-
tory infiltrate with fimbrial type. Kidneys injected with PBS
appeared histologically and morphologically normal with a
negligible degree of scarring and infiltrate at the puncture site.
Chemiluminescence (CL) response of human PMN
The strains of E. coIl used in the kidney scarring experiments
and expressing Type I fimbria, whether alone or in conjunction
with P-fimbria, generated 10 to 100 times more luminol-depen-
dent chemiluminescence (CL) than P-fimbriate or non-fimbriate
strains (Z = —2.77 and —2.69, respectively, P < 0.01; Fig. 3).
In addition the generation of CL by a particular strain following
subculture in at least one of four culture media (Table 2)
correlated significantly with the area of scarring caused by that
same strain in the rat kidneys following growth in the same
media (Z = 2.16; P < 0.05; Fig. 4).
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Fig. 5. Release of neutral protease from PMN (expressed as the % of
total protease activity released following PMN sonication)following 60
mm incubation at 3C with each of E. coli strains which had been
grown in static nutrient broth or on DST agar (Table 2). Each point
represents the mean of duplicate determinations obtained in 3 experi-
ments with PMN from different donors and with strains expressing the
same fimbriation pattern as in Fig. lB.
.
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Fig. 6. Area of external scars of rat kidneys 6 weeks after injection of
one of the strains of E. coli which had been grown in nutrient broth or
on DST agar (Table 2) compared with the release of PMN neutral
protease (expressed as % of total protease activity released following
PMN sonication) after 60 mm incubation at 3C with the same strain
expressing the same fimbriation phenotype. Each point represents the
mean scar area of 6 kidneys injected with the same organism compared
with the mean neutral protease release from PMN obtained from 3
separate donors.
Discussion
The external surface area of the renal scars produced by Type
1 fimbriate E. co/i in an animal model of chronic pyelonephritis
was significantly greater than the scars produced by P-fimbriate
and non-fimbriate strains. Human PMN were stimulated by the
same Type I fimbriate strains, with activation of the respiratory
burst and release of lysosomal neutral protease activity. The in
vitro response of human PMN correlated significantly with the
area of the scar produced by the same strain in the animal
model. In contrast, the degree of inflammatory cell infiltration
at six weeks after infection did not significantly correlate with
the fimbrial expression of the injected strain. This is not
altogether unexpected since previous studies have indicated
that it is the initial inflammatory cell activation which is related
to the formation of a scar rather than the degree of subsequent
mononuclear cell (MNC) infiltration [6—b]. Neutrophils invade
the site of infection from six hours following injection and are
then replaced by MNC over a period of days [7]. In addition,
antibiotic therapy is only effective in preventing scar formation
when administered within 24 hours [6, 7], suggesting that it is
the initial PMN/E. cot! interaction which is responsible for the
initiation of scarring.
It has previously been demonstrated using intact organisms
[19, 211 and confirmed using isolated fimbria [26], that the
possession of Type I fimbria correlates significantly with the
activation of the respiratory burst and with the time- and
dose-dependent degranulation response of human PMN [20].
The neutral protease activity released during this interaction
and measured as degradation of [1H1-casein is almost entirely
due to the serine protease, elastase, which is located in the
azurophil granule and which is released only by potent stimuli
such as the calcium ionophore A23187 [20]. This protease is
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FIg. 7. Area of external scar of rat kidneys 6 weeks after injection of
one of 13 strains of E. coli grown in nutrient broth compared with the
optimum hemolytic capacity of that strain. Each point represents the
mean scar area of 6 kidneys injected with each organism compared to
the mean of triplicate determinations of the hemolytic capacity of the
same strain bearing the same phenotypic fimbrial characteristics.
active against basement membrane constituents [27] and the
release of elastase could be a major feature of the initiation of
this tissue damage resulting in scar formation [20]. In addition,
toxic oxygen metabolites such as O, and OH released
during the respiratory burst may also be involved in the
initiation of tissue damage [22, 23, 28, 29].
In contrast to the widely published data on the frequency in
urinary isolates of organisms genetically capable of MRHA
expression [12, 13, 17, 32, 331, the presence of genotypic Type
I fimbriate organisms among urinary isolates has received much
less attention, even though they are found with a similar
frequency [30—33]. Clinically, it has been established that renal
scarring occurs more commonly in patients with a history of
UTI associated with vesico-ureteric reflux (VUR) [2—4]. In a
recent study it was demonstrated that bacteria isolated in the
presence of VUR, particularly E. cot!, had a significantly lower
genetic potential for the expression of "standard" virulence
markers (such as MRHA) than did those strains causing unob-
structed acute pyelonephritis in the absence of VUR [17]. It
follows that those strains of E. co/i most likely to cause renal
scarring are apparently less virulent by "standard" criteria than
non-scarring organisms, and therefore, that VUR enables a
particular "non-virulent" [12, 13] population of bacteria to
reach the renal parenchyma and therein initiate renal scarring.
The data presented here support the concept that the expres-
sion of MRHA of P-fimbriae by strains of E. co/iis probably not
important in the initiation of the scarring process, although the
binding of fimbriate bacteria to the cells lining the kidney tubule
and the urinary tract may initiate the process of PMN recruit-
ment in vivo to the site of infection. Thus the virulence factors
associated with tissue damage and eventual renal scarring are
different from those bacterial traits associated either with
colonization of the bladder or acute non-obstructed pyelone-
phritis [17].
The association between nephropathogenicity and the in vitro
capacity to elaborate a-hemolysin is well documented [15, 16,
34, 35]. Recent evidence has linked the release of the chemo-
tactic mediator leukotriene B4 (LTB4), from PMN stimulated
either by strains of E. cot! or their culture filtrates, with the
ability of the same strains to elaborate a-hemolysin [36, 37].
.
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The results presented here, however, show no quantitative
correlation between in vitro a-hemolysin production and renal
scarring. These findings could indicate that, while the produc-
tion of the potent chemotaxin LTB4 may regulate the extent and
outcome of the inflammatory response, it is probably not
involved in the initiation of that response.
In conclusion, we have demonstrated that the ability of E.
co/i strains, with defined virulence characteristics to cause
scarring in an animal model is, to a significant extent, dependent
on both the phenotypic and genotypic expression of Type 1
fimbriae and that the activation of PMN may represent the
mechanism by which this is initiated. It is now established that
the binding of Type I fimbria is dependent on the expression of
a 28 kD protein at the fimbrial tip [38] and in addition, that the
interaction with the PMN membrane may be mediated through
the specific binding of these fimbria to membrane glycoproteins
comprising the receptor for the inactive cleavage product of C3
(C3bi) [39]. Isogenic strains, mutated to change individual
virulence characteristics, and used to activate PMN and initiate
scarring, would allow further elucidation of this mechanism by
eliminating other, potentially variable bacterial characteristics.
The phenotypic expression of bacterial traits, particularly
fimbria, is dependent on phase variation, which will be con-
trolled by the environmental conditions in which the organisms
are growing [33, 40—43]. Thus, phenotypic expression in vitro
will not necessarily reflect in vivo expression. The demonstra-
tion of the expression of Type I fimbria in situ would add
significantly to the correlation of in vitro and in vivo findings
and lead to further insight into the mechanisms of the scarring
process.
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